Opinion: Companies must responsibly manufacture the antimicrobials society needs
In a world challenged by microbes resistant to antibiotics, many medical interventions that rely on…
Author: STAT
STAT Plus: Medical data startup Syapse cuts 10% of workforce as it prioritizes data analytics and insights
SAN FRANCISCO — Syapse, among the highest profile companies in a wave of startups seeking…
STAT Plus: Spring Bank scraps hepatitis R&D after patient dies in trial
Spring Bank Pharmaceuticals (SBPH) said Wednesday it was abandoning efforts to develop a drug to…
WHO to reconvene emergency committee to assess global coronavirus threat
The leader of the World Health Organization said Wednesday he will convene another meeting of…
STAT Plus: Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies
Good morning, everyone, and welcome to the middle of the week. You made it this…
In coronavirus response, AI is becoming a useful tool in a global outbreak, data experts say
A version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe. Artificial intelligence…
Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter
Zolgensma, the Novartis gene therapy for infants and the world’s most expensive medicine, continues to…
STAT Plus: In a pivot, Decibel Therapeutics loses its founding CEO — and some of its discovery programs
Decibel Therapeutics CEO Steven Holtzman is really, officially retiring. The departure of the longtime vet…
Three star scientists announce plan to solve biotech’s ‘missing women’ problem
They are the biotech equivalent of the “missing girls” in countries with a skewed gender…
Opinion: Biotech can — and must — reshape the pricing debate and protect future innovation
The week before the craziness known as J.P. Morgan 2020 began, more than 300 biotech…
STAT Plus: The FDA wants to know how Instagram influencers sway patient views on medicines
In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social…
STAT Plus: With new rules, FDA aims to spark competition, lower prices for expensive gene therapies
WASHINGTON — The Food and Drug Administration released a slew of gene therapy policies Tuesday…
STAT Plus: Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
Federal prosecutors this week announced a $145 million settlement with an electronic health records company…
Drug makers face more securities-fraud lawsuits, and so do cannabis companies
The number of class-action lawsuits claiming securities fraud committed by life sciences companies climbed to…
Top Harvard chemist charged with lying about ties to Chinese government program
The head of Harvard University’s chemistry department was charged on Tuesday with attempting to conceal…
Federal officials tell China: Let U.S. health workers enter to help respond to coronavirus
WASHINGTON — Federal officials on Tuesday called for a team of Americans to be allowed…
STAT Plus: Biotech earnings preview: Unsettled investors hoping for strong 2020 outlooks
Biotech earnings season kicks off Thursday with fourth-quarter reports from Alexion Pharma (ALXN), Amgen (AMGN),…
.jpg)
STAT Plus: Pharmalittle: Insulin dominates Democrats’ health agenda in Iowa; FDA studies Instagram influencers
Good morning, everyone. The world is watching China, the new coronavirus, and the outbreak’s spread….
TB vaccines can vary greatly, study finds. But does that mean some are less protective?
It all started with a bit of bacteria swiped from the udder of a tuberculous…
Opinion: ‘Small’ tactics to counter Big Pharma’s influence on medication overload
Money talks in Washington, D.C., and no sector of the economy speaks more loudly than…
It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
WATERLOO, Iowa — Presidential candidates can’t stop talking about insulin. At a campaign stop here…
He once sent untrue, alarmist tweets about Ebola. Now, Trump is facing his biggest outbreak emergency — and experts are worried
WASHINGTON — When Ebola was spreading in West Africa in 2014, Donald Trump took to…
The coronavirus questions that scientists are racing to answer
The outbreak of a novel coronavirus in China and its spread to more than a…
STAT Plus: Acceleron pulmonary hypertension drug succeeds in mid-stage clinical trial
Acceleron Pharma said Monday that a mid-stage clinical trial involving an experimental drug for pulmonary…
Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market
More than four years after Martin Shkreli incensed Americans by raising the price of a…
Opinion: An ‘Epic’ pushback as U.S. prepares for new era of empowering patient health data
Epic, the largest electronic health record company in the U.S., launched an effort last week…
STAT Plus: Big drug purchasers predict price hikes driven by expensive new therapies
More than two dozen big buyers of prescription medicines expect that prices will rise by…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
Opinion: Bird flu. SARS. China coronavirus. Is history repeating itself?
HONG KONG — Sometimes history seems to unspool in a continuous playback loop. That is…
STAT Plus: Roche is fined by Romania for thwarting competition to its cancer medicines
Following a two-year investigation, Roche (RHHBY) was fined $14 million by antitrust authorities in Romania…
STAT Plus: The suburbs are cheaper, but they don’t have what Kendall Square has for biotechs: serendipity
You know Kendall Square’s office rents have gotten stratospheric when a CEO compares the neighborhood…
STAT Plus: Pharmalittle: Coronavirus spread may hurt pharma’s supply chain; Illinois limits out-of-pocket insulin costs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: ‘The gurus of sperm’: Ohana Biosciences is taking a different approach to fertility
“Ohana” means family in Hawaiian — and the new Cambridge, Mass.-based biotech that took that…
‘The time to worry is now’: The coronavirus in China could threaten pharma’s ingredient sourcing
As a novel coronavirus spreads through China and rattles the rest of the world, the…
Opinion: Epic’s call to block a proposed data rule is wrong for many reasons
Epic, the nation’s largest electronic health record (EHR) company and a major beneficiary of a…
Opinion: The cannabis boom could be good for science — and scientists
I’ve been a chemistry professor for 15 years and a chemist for longer than that….
STAT Plus: These 10 startups acquired by Alphabet reveal a health care play centered on surveillance
At a gathering of the world’s business and political titans last week, Google CEO Sundar…
Containing new coronavirus may not be feasible, experts say, as they warn of possible sustained global spread
Some infectious disease experts are warning that it may no longer be feasible to contain…
DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations
As infectious disease specialists and epidemiologists race to contain the outbreak of the novel coronavirus…
STAT Plus: Another patient charity settles charges it helped drug makers pay Medicare kickbacks
After a contentious, two-year battle with federal authorities, a patient charity called Patient Services agreed…
How fast can biotech come up with a vaccine for the latest outbreak?
The deadly outbreak of a novel coronavirus has sparked a race among biotech companies, each…
STAT Plus: What does the latest twist in the Sarepta saga mean for the future of the FDA? We discuss
Earlier this week, the Food and Drug Administration released documents that reveal a schism within…
New coronavirus can cause infections with no symptoms and sicken otherwise healthy people, studies show
Two papers published Friday in the journal the Lancet offer some of the first rigorous…
STAT Plus: Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme
The founder of Insys Therapeutics was sentenced to 5½ years in federal prison Thursday for…
‘Traumatic as hell’: Patients describe what it’s like to be restrained in the ER
Sometimes, in especially intense moments in the emergency room, a staffer might have to take…
CDC reports second U.S. case of novel virus spreading in China
A second case of the new infection emerging from China has been discovered in the…
STAT Plus: Pharmalittle: Drug makers spent $120 million lobbying Congress in 2019; more investors are bullish in Biogen’s Alzheimer drug
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Using social norms to drive positive changes in health
Well-intentioned efforts to help others often backfire, but we can learn from our mistakes. Vaping…
Opinion: Questionable study casts a cloud over the 75th anniversary of water fluoridation
Seventy-five years ago, on Jan. 25, 1945, public health officials began an experiment in Grand…